|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Serum CA19-9 Response as a
Surrogate for Clinical Outcome in Patients Receiving Fixed-Dose
Rate Gemcitabine for Advanced Pancreatic Cancer Br J Cancer. 2005 Jul 25;93(2):195-9. PMID: 15999098
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |